Webinar hosted by the National Institute on Drug Abuse and the Coalition for Global Hepatitis Elimination
Thursday, May 4th | 11am-1pm ET
The next webinar in the "Moving from Hepatitis Discovery to Elimination: NIH Research Advancing Hepatitis Elimination" series will be hosted by the National Institute on Drug Abuse. Speakers will discuss collaborative research on hepatitis C networks among persons who inject drugs, using peers and technology to increase uptake of HCV screening and treatment, and hepatitis C elimination among persons injecting drugs in Mexico during the COVID-19 pandemic.
Presentations will include:
- Dr. Todd Allen, Professor of Medicine, Harvard Medical School | Collaborative research on Hepatitis C networks among persons who inject drugs using next generation genetic sequencing technology
- Dr. Todd Korthuis, Professor of Medicine, Oregon Health Sciences University | Using peers and technology to increase uptake of HCV screening & treatment and substance use disorder treatment among people who use drugs in rural Oregon
- Dr. Natasha K. Martin, Professor of Medicine, University of California San Diego | Hepatitis C elimination among people who inject drugs in Mexico during the COVID-19 pandemic
A round-table discussion will follow with comments from:
- Holly Hagan PhD, MPH; Director, NIDA P30 Center for Drug Use and HIV|HCV Research at Global Public Health; Professor, NYU School of Global Public Health
- Yngvild K. Olsen MD, MPH; Director of the Center for Substance Abuse Treatment (CSAT); SAMHSA
- Eyasu Teshale, MD: Division of Viral Hepatitis; CDC
- Carolyn Wester MD, MPH; Director, Division of Viral Hepatitis; CDC
- View the first year of the webinar series presenting the latest research related to HCV testing and treatment among persons who use drugs and/or incarcerated.
- View the second year of the webinar series presenting on collaborative research on expanding access to hepatitis C prevention, testing and treatment and treatment of drug abuse within the criminal justice system: